help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 19, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0352
A more recent version of this article appeared on September 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/9/3689    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hainerová, I.
Right arrow Articles by Pedersen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hainerová, I.
Right arrow Articles by Pedersen, O.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Pediatric Endocrinology
Right arrow Obesity

Submitted on February 15, 2007
Accepted on June 8, 2007

Melanocortin 4 Receptor Mutations in Obese Czech Children: Studies of Prevalence, Phenotype Development, Weight Reduction Response and Functional Analysis

Irena Hainerová*, Lesli H. Larsen, Birgitte Holst, Marie Finková, Vojtech Hainer, Jan Lebl, Torben Hansen, and Oluf Pedersen

Department of Pediatrics and Center for Research of Diabetes, Metabolism and Nutrition, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic (I.H., M.F.); Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Copenhagen, Denmark (L.H.L., T.H., O.P.); Department of Pharmacology, University of Copenhagen, Denmark (B.H.), Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic (V.H.); Department of Pediatrics, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic (J.L.); Danish Epidemiology Science Center, Institute of Preventive Medicine, Copenhagen University Hospital, Denmark (L.H.L.); Faculty of Health, University of Aarhus, Aarhus, Denmark (O.P.)

* To whom correspondence should be addressed. E-mail: ihainer{at}hotmail.com.

Background: Mutations in the melanocortin 4 receptor gene (MC4R) represent the most common known cause of monogenic human obesity.

Aims: 1) to estimate the prevalence of MC4R mutations in obese Czech children, 2) to evaluate phenotypic features of the mutation carriers, 3) to compare weight, height and body mass index (BMI) of MC4R mutation carriers with non-carriers in longitudinal studies, 4) to determine the effect of a weight management among MC4R mutation carriers and 5) to perform a functional analysis of a novel variant

Subjects and methods: We analyzed the coding region of MC4R in a cohort of 289 Czech children and adolescents with early-onset obesity by direct sequencing. Information on weight, height, BMI, baseline biochemical data and a weight loss follow-up study were obtained. In vitro functional analysis of one novel variant was performed.

Results: We identified six different mutations in seven probands: one novel missense mutation Cys84Arg, and five previously reported variants, Arg7Cys, Ser19fsdelA, Phe51Leu, Ser127Leu and Gly181Asp. The Gly181Asp variant was detected in one homozygous carrier from unrelated parents. None of the mutation carriers fulfilled the MC4R syndrome criteria. A comparison of anthropometrics in mutation carriers and non-carriers during 13 years of follow-up did not reveal any significant differences. MC4R mutation carriers exhibited a similar ability to lose weight as obese non-carriers. The novel variant Cys84Arg showed a significant reduction in cAMP signal properties of the MC4R.

Conclusions: Among Czech obese children, we found a prevalence of 2.4% of MC4R homozygous and heterozygous mutations and showed a similar response to diet management of MC4R mutation carriers and non-carriers.


Key words: Obesity • melanocortin 4 receptor • mutation • children • MC4R cAMP activity




This article has been cited by other articles:


Home page
Diabetes CareHome page
V. Hainer, H. Toplak, and A. Mitrakou
Treatment Modalities of Obesity: What fits whom?
Diabetes Care, February 1, 2008; 31(Supplement_2): S269 - S277.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society